Chemo-ribosomal synthesis of atropisomeric and macrocyclic peptides with embedded quinolines

10 June 2024, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Expanding the chemical and structural complexity of genetically encoded peptides remains a challenge in peptide therapeutics discovery. Here we report that linear peptides with a reactive β- or γ-keto amide at their N-termini can be synthesized ribosomally using in vitro translation methods. We show that peptides carrying an N-terminal β-keto amide can be converted into diverse heterocyclic quinoline-peptide hybrids via Friedländer reactions with a variety of 2-aminoarylcarbonyl co-substrates. Reactions with appropriately substituted 2-aminobenzophenones generated quinoline-peptide hybrids with stable biaryl atropisomeric axes. In vitro-translated peptides carrying both an N-terminal β-keto amide and an internal 2-aminoacetophenone motif undergo intramolecular Friedländer macrocyclization reactions that embed a quinoline pharmacophore directly within the macrocyclic backbone. The introduction of N-terminal ketide building blocks into genetically encoded materials and their post-translational derivatization with carbonyl chemistry simultaneously expands the chemical diversity and structural complexity of genetically encoded materials and provides a paradigm for the programmed synthesis of peptide-derived materials that more closely resemble complex natural products.

Keywords

Peptides
Atropisomers
Macrocycles
Ribosomes

Supplementary materials

Title
Description
Actions
Title
Supporting Information
Description
Supplementary Figures, Experimental Methods and Processed Data
Actions
Title
FAIR Data
Description
FID Files and other Raw Data
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.